Valeant shares sink again despite new denials in Philidor crisis

Valeant stock drugs

Valeant Pharmaceuticals laid out a comprehensive refutation of the fraud allegations that have been raised against it by a short-seller, but the denials failed to halt the slide in the company's shares on Monday.



from CBC | Health News http://ift.tt/1XtnPwW

Share this:

ABOUT THE AUTHOR

Hello We are OddThemes, Our name came from the fact that we are UNIQUE. We specialize in designing premium looking fully customizable highly responsive blogger templates. We at OddThemes do carry a philosophy that: Nothing Is Impossible

0 commentaires:

Enregistrer un commentaire